catalyst grant: methods in post-market drug safety and effectiveness research
the aim of these cihr catalyst grants is to provide seed money, on a short-term basis, to support capacity building in specific health research areas.
within the framework of the catalyst grant program objectives, the specific objectives of this funding opportunity are to:
- promote and increase capacity in innovative and cost-effective trial designs.
- stimulate researchers from various backgrounds to explore new methodologies.
examples of activities that might be conducted under this funding opportunity (but are not restricted to) are:
- planning and execution of pilot projects or feasibility studies to generate preliminary data, proof of concept.
- development and/or validation of new tools, methodologies and/or protocols.
- develop critical steps in the research needed to deliver research results.
more specifically, this funding opportunity will address post-market drug safety and effectiveness research using each of the following methodologies through the following funding pools:
- registry-randomized trials
- direct patient reporting of post-market outcomes
- bayesian methods and statistical models